Anterior ischemic optic neuropathy in pediatric peritoneal dialysis: risk factors and therapy

Pediatr Nephrol. 2014 Jul;29(7):1249-57. doi: 10.1007/s00467-013-2747-6. Epub 2014 Feb 2.

Abstract

Background: Sudden blindness caused by anterior ischemic optic neuropathy (AION) is a rare complication for patients undergoing peritoneal dialysis (PD). Prognosis is generally poor, with AION commonly resulting in permanent visual loss.

Methods: We first describe four case reports of children with AION during PD treatment. We then review ten additional AION cases reported in the literature and compare these 14 affected patients with a control cohort of 59 non-affected patients in the Vienna PD registry.

Results: Significant risk factors for AION were identified as median age (4 vs. 27 months; p < 0.001), autosomal recessive polycystic kidney disease (28.6 vs. 3.4%; p = 0.01), anephric status (53.8 vs. 6.8%; p < 0.001) and low to normal blood pressure evidenced by the number of patients having to be treated with antihypertensive medications (14.3 vs. 62.7%; p = 0.01). Severe hypovolemia was reported in 50% of all cases. Outcome was visual loss with optic atrophy in nine patients; five patients had a good visual outcome. The major difference in treatment was a rapid bolus of saline within 12 h after the initial symptoms.

Conclusions: Young age, autosomal recessive polycystic kidney disease, anephric status and hypotension are substantial risk factors for AION. Early hospitalization with vascular refilling within a few hours following onset of blindness leads to improved visual outcome.

MeSH terms

  • Adolescent
  • Age Factors
  • Child, Preschool
  • Female
  • Humans
  • Hypotension / complications
  • Infant
  • Male
  • Optic Neuropathy, Ischemic / etiology*
  • Optic Neuropathy, Ischemic / therapy
  • Peritoneal Dialysis / adverse effects*
  • Polycystic Kidney, Autosomal Recessive / complications
  • Risk Factors